Terms: = Bone cancer AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR AND Diagnosis
4 results:
1. Ultra-Sensitive
Klimiankou M; Uenalan M; Kandabarau S; Nustede R; Steiert I; Mellor-Heineke S; Zeidler C; Skokowa J; Welte K
Front Immunol; 2019; 10():116. PubMed ID: 30891028
[TBL] [Abstract] [Full Text] [Related]
2. Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample Collection.
Patel KP; Ruiz-Cordero R; Chen W; Routbort MJ; Floyd K; Rodriguez S; Galbincea J; Barkoh BA; Hatfield D; Khogeer H; Kanagal-Shamanna R; Yin CC; Zuo Z; Loghavi S; Ok CY; DiNardo CD; Luthra R; Medeiros LJ
J Mol Diagn; 2019 Jan; 21(1):89-98. PubMed ID: 30577887
[TBL] [Abstract] [Full Text] [Related]
3. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with csf3r mutation: a case report and literature review.
Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y
BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671
[TBL] [Abstract] [Full Text] [Related]
4. Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management.
Elliott MA; Tefferi A
Am J Hematol; 2018 Aug; 93(4):578-587. PubMed ID: 29512199
[TBL] [Abstract] [Full Text] [Related]
